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Introduction. Quantifying the number of years gained (YLG) associated with light-intensity 30 
physical activity (LPA) may be important for risk communication in public health. With no 31 
studies having examined the role of LPA in life expectancy, this study aims to quantify YLG 32 
from LPA in a population-based US sample.   33 
 34 
Methods. This study used data from 6,636 participants in the National Health and Nutrition 35 
Examination Survey (2003-2006). The analyses were conducted in 2020. LPA was 36 
categorized into low, medium, and high based on tertiles, and survival models were applied 37 
to estimate YLG from each LPA group. The analyses were repeated in participants with 38 
MVPA above or below the median. 39 
 40 
Results. During a mean follow-up of 11 years and 55,520 person-years, 994 deaths were 41 
recorded. At age 20, participants with low, medium and high LPA had a predicted life 42 
expectancy of 55.70 (48.70 – 62.70), 58.96 (52.17 –  65.75) and  60.60 (54.03 – 67.18) years, 43 
suggesting significant YLG from medium and high levels of LPA of 3.45 (0.77 – 6.12) and 44 
5.24 (1.88 – 8.60) years. Corresponding YLG at age 45 and 65 was 2.93 (0.40 – 5.47) and 45 
1.98 (0.03 – 3.94) years for the medium LPA group, and 4.53 (1.26 – 7.80) and 3.10 (0.42 – 46 
5.78) years for the high LPA group. This association was significant in participants with 47 
below-median MVPA but not for those with above-median MVPA. 48 
 49 
Conclusion. LPA may extend life expectancy. Given the low prevalence of MVPA in 50 
populations, physical activity promotion efforts may capitalise on emerging evidence on 51 





Levels of moderate-to-vigorous-intensity physical activity (MVPA) are low despite numerous 56 
benefits, including reduced risk of premature mortality and increased life expectancy.1 To 57 
date, physical activity guidelines have focused primarily on MVPA. 2 Recent evidence 58 
suggests that light-intensity physical activity (LPA), defined as activities of 1.5-3 metabolic 59 
equivalents (e.g. slow walking), may also offer health benefits, 5, 6 particularly among people 60 
with low levels of MVPA. 7 Evidence on LPA and mortality has been identified as a “major 61 
future research need” 2. Quantifying the number of years gained (YLG) associated with LPA 62 
may be important for informing policies and guidelines in public health. This study aims, for 63 






The current prospective analysis used data from the 2003-2004 and 2005-2006 waves of the 70 
National Health and Nutrition Examination Survey (NHANES), a stratified, multistage 71 
probability sample representative of the civilian non-institutionalized U.S. population. 8 Data 72 
were linked to death records from the National Death Index through December 31, 2015. 73 
Participants were 18 years or over with at least 1 valid day (> 10 hours of wear time per day) 74 
of accelerometry data (n= 8,410), and we reran analysis based on participants with 4+ valid 75 
days of data as sensitivity analysis. 3 Considering that those with occult disease were less 76 
 4 
likely to be active, we left-truncated the sample at 2 years of follow-up (176 deaths). 9 The 77 
final analytic sample contained 6,636 participants (Figure 1). 78 
 79 
 80 
Details regarding accelerometry measures have been fully documented. 3 Briefly, participants 81 
wore accelerometers (AM-7164, ActiGraph, LLC, Fort Walton Beach, Florida) on their waist 82 
and data reduction followed validated procedures. 3 Using established cut-points,3, 10 physical 83 
activity was classified into LPA (100-760 counts/min) and MVPA (2020+ counts/min). 84 
Participants were categorized into LPA tertiles: low (73.05 to 216.57 min/day), medium 85 
(216.60 to 276.83 min/day) or high (276.85 to 433.97min/day). Using NHANES sample 86 
weights, a flexible parametric survival framework 11 with age as the time scale was used to 87 
model the effects of baseline LPA groups on all-cause mortality. Calculation of YLG from 88 
LPA involved a two-step process: first, the residual life expectancy for each LPA tertile was 89 
estimated as the area under the survival curve (AUC) up to 100 years, conditional on 90 
surviving at ages 20 to 100 years old (1-year intervals); then, survival curves were predicted 91 
for each individual and averaged them across individuals. Then YLG were calculated as the 92 
differences in the average AUC for the LPA medium/high groups, compared with the low-93 
LPA group (reference). 11 Finally, the analyses were repeated in participants with MVPA 94 
above or below the median (14 min/day). All models were adjusted for sex, ethnicity, 95 
education, smoking status, alcohol intake, body mass index, presence of medical conditions, 96 
mobility limitations, family poverty ratio, marital status, and accelerometer measures (MVPA 97 
and wear time). Analyses were conducted in 2020 in Stata 15. The alpha was set at 0.05, two-98 







On average, participants wore accelerometers for 865 minutes per day, of which 251 minutes 105 
were LPA. Those who had low LPA were older and more likely to be male, White, university 106 
graduate, not in a married relationship, and have more medical conditions (Table 1).  107 
 108 
 109 
During a mean follow-up of 11 years and 55,520 person-years (n= 6,636), 994 deaths were 110 
recorded. Compared with the low LPA group, participants in the medium and high LPA 111 
groups had a lower risk of all-cause mortality (HR [95% CI]: 0.71 [0.58 – 0.86], 0.59 [0.47 – 112 
0.74] respectively). At age 20, participants with low, medium and high LPA had a predicted 113 
life expectancy of 55.70 (48.70 – 62.70), 58.96 (52.17 –  65.75) and  60.60 (54.03 – 67.18) 114 
years, suggesting significant YLG from medium and high levels of LPA of 3.45 (0.77 – 6.12) 115 
and 5.24 (1.88 – 8.60) years. Corresponding YLG at age 45 and 65 was 2.93 (0.40 – 5.47) 116 
and 1.98 (0.03 – 3.94) years for the medium LPA group, and 4.53 (1.26 – 7.80) and 3.10 117 
(0.42 – 5.78) years for the high LPA group (Figure 2). Further stratified analysis revealed that 118 
the association was significant in those with MVPA at or below-median (< 14 min/day, mean 119 
[SD]: 5.75 [4.17]) with YLG of 3.23 (0.54 – 5.92), 3.02 (0.16 –   5.88) and 2.35 (0.08 – 4.63) 120 
at an age of 20, 45, and 65 for medium LPA and 4.25 (1.02 – 7.48), 3.99 (0.49 – 7.49) and 121 
3.12 (0.27 – 5.97) for high LPA. However, the YLG was not significantly different from zero 122 
for those with above-median MVPA (mean [SD]: 37.44 [21.91]). Results were consistent 123 







This is the first study to estimate YLG from accelerometer-derived LPA. Consistent with 130 
previous studies, 5, 6 the current findings suggest that LPA could add years to life, particularly 131 
among those with low MVPA.  132 
 133 
 134 
The lack of repeated LPA measures limits our ability to claim causality. Despite left-135 
truncation and statistical adjustment, reverse causation may still be present. Nearly 13% of 136 
participants were removed from analyses due to invalid accelerometer data, introducing 137 
selection bias. Mortality was low amongst participants aged 40 years or less (~5%). 138 
Furthermore, confidence intervals associated with estimated YLG are wide and need to be 139 
interpreted with caution. Moreover, accelerometers may not be able to accurately 140 
differentiate between sedentary behavior (low energy sitting) and LPA. The definition of 141 
LPA in the current study may not differentiate from MVPA (in relative terms) in the elderly 142 
and those with low cardiorespiratory fitness. Finally, because there is no established cut-off 143 
point for the recommended amount of LPA, we modelled YLG based on data distribution 144 
(i.e., tertiles), which limits the public health interpretation of our findings.  145 
 146 
 147 
A recent meta-analysis based on a small number of studies reported moderately consistent 148 
evidence for the protective effects of LPA on cardiometabolic health while indicating an 149 
inverse association between LPA and all-cause mortality. 3 Several studies of varied quality12 150 
have examined associations between LPA and all-cause mortality using NHANES data. 13-15 151 
 7 
These revealed different findings, suggesting that conclusions may be subject to analytical 152 
decisions and other methodological issues, such as follow-up periods, left-truncation of data, 153 
and whether to include participants with insufficient valid accelerometer data. 9  154 
 155 
 156 
From a public health perspective, YLG is a more intuitive metric than others such as HR and 157 
may facilitate communication of the benefits of physical activity. 16 Moreover, understanding 158 
the effects of health behaviour on YLG is an essential tool in epidemiology, and can be 159 
supplemented by the quality of life experienced during those additional years. The modelling 160 
strategy in this study (i.e., flexible parametric approach) has demonstrated advantages over 161 
more traditional survival methods (e.g., Cox or parametric), including not being influenced 162 
by the proportional hazard assumption. 16, 17 The current results and previous evidence 18, 19 163 
suggest that the protective effects of LPA on mortality may be limited to people who 164 
accumulate little or no MVPA. 3 The established dose-response effects of physical activity 20 165 
suggest that the greater stimulus of MVPA would be expected to largely override the health 166 







Compared with MVPA, LPA is mostly incidental in nature without requirements for 174 
equipment, facilities, or high levels of fitness, skills or motivation, and therefore, may be 175 
more feasible and accessible to the broader population. 5Encouraging and facilitating LPA 176 
 8 
through public health programs and environmental and policy interventions could be 177 
considered a viable and complementary strategy to promoting MVPA. 21 Promoting LPA 178 
may be particularly relevant for people unable to meet the current public health 179 
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Figures titles and footnotes 298 
Figure 1. STROBE participant flow diagram 299 
Figure 2. Years of life gained by baseline accelerometer-derived light-intensity physical 300 
activity: medium and high vs low (reference). Graph a represents the years of life gained from 301 
various levels of LPA in the study sample. Low LPA group (i.e., reference) corresponds to 302 
73.05 to 216.57 min/day of LPA; medium LPA group corresponds to 216.60 to 276.83 303 
min/day; and high LPA group corresponds to 276.83 to 433.97 min/day. The Graphs b and c 304 
represent life expectancy associated with LPA for participants with moderate-to-vigorous 305 
physical activity (MVPA) at or below the median (14 min/day, b) and above the median (c). 306 
All models are adjusted for self-reported sex, ethnicity, education, marital status, poverty ratio, 307 
presence of medical conditions, mobility limitations, smoking status, alcohol intake, MVPA 308 
























n=6,636 n=2,068 n=2,234 n=2,334  
Deaths, n 994 507 267 220  








(16.41)  <0.001 
Body Mass Index (kg/m2) 28.69 (6.47)  29.13 (7.17)  28.50 (6.19)  28.48 (6.06)  0.018 
Sex: Female (%) 49.61%  43.33%  49.33%  55.44% <0.001 
Unable to walk for a quarter mile (%)  1.07%  1.98%  0.72%  0.60% <0.001 
Family income-poverty ratiob 2.68 (1.59)  2.72 (1.63)  2.78 (1.60)  2.54 (1.53)  <0.001 
Race/ ethnicity (%)     <0.001 
   White, non-Hispanic  51.76%  57.69%  53.04%  45.29%  
   Black, non-Hispanic  21.38%  21.08%  20.55%  22.45%  
  Mexican American 19.85%  14.65%  19.70%  24.59%  
  Other Hispanic  2.97%  2.32%  2.91%  3.60%  
  Other Race, including Multi-Racial  4.04%  4.26%  3.80%  4.07%  
Education %     <0.001 
  Less than 9th Grade  12.91%  11.56%  12.26%  14.74%  
   9-11th grade or less   14.30%  14.12%  13.21%  15.51%  
   High school or equivalent  24.53%  20.31%  24.40%  28.41%  
   Some college or equivalent  28.60%  27.95%  29.63%  28.19%  
   University graduate or above  19.65%  26.06%  20.50%  13.15%  
 16 
Marital status %     <0.001 
Married  55.47%  49.90%  57.16%  58.78%  
Widowed  9.18%  13.01%  7.74%  7.16%  
Divorced  10.28%  10.06%  10.70%  10.07%  
Separated  2.85%  2.47%  2.69%  3.34%  
Never married  15.37%  17.75%  15.31%  13.32%  
Living with partner  6.86%  6.82%  6.40%  7.33%  
Asthma %  12.25%  14.22%  11.15%  11.57% 0.004 
Arthritis %  27.52%  32.88%  26.14%  24.08% <0.001 
Heart Failure %  3.25%  6.00%  2.33%  1.71% <0.001 
Angina %  3.60%  5.66%  3.45%  1.93% <0.001 
Coronary Heart Disease %  4.45%  7.74%  3.67%  2.27% <0.001 
Heart Attack %  4.54%  7.40%  4.12%  2.40% <0.001 
Stroke %  3.42%  5.80%  2.69%  2.01% <0.001 
Emphysema %  2.02%  3.53%  1.25%  1.41% <0.001 
Liver condition %  3.12%  3.63%  3.00%  2.78% 0.300 
Cancer %  8.92%  12.19%  8.37%  6.56% <0.001 
Current smokingc % 35.85% 36.27% 35.32% 35.99% 0.810 
Alcohol intake >10 g/day %  25.09%  24.52%  25.34%  25.36% 0.810 































Boldface indicates statistical significance. 
Data are presented as mean SD for continuous measures, and % for categorical measures. 
aLPA, light-intensity physical activity. LPA groups are based on tertiles: low LIPA corresponds to 73.05 to 216.57 
min/day; medium LPA corresponds to 216.60 to 276.83 min/day; and high LPA corresponds to 276.85 to 433.97 
min/day.  
bFamily income-poverty ratio is calculated by dividing family income by the poverty guidelines, specific to family size, 
as well as the appropriate year and state.  
cCurrent smoking was defined as the serum level of cotinine exceeding >10 ng/mL.  
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